Literature DB >> 3405207

Tumor necrosis factor inhibits human myogenesis in vitro.

S C Miller1, H Ito, H M Blau, F M Torti.   

Abstract

We examined the effects of human recombinant tumor necrosis factor-alpha (TNF) on human primary myoblasts. When added to proliferating myoblasts, TNF inhibited the expression of alpha-cardiac actin, a muscle-specific gene whose expression is observed at low levels in human myoblasts. TNF also inhibited muscle differentiation as measured by several parameters, including cell fusion and the expression of other muscle-specific genes, such as alpha-skeletal actin and myosin heavy chain. Muscle cells were sensitive to TNF in a narrow temporal window of differentiation. Northern (RNA) blot and immunofluorescence analyses revealed that human muscle gene expression became unresponsive to TNF coincident with myoblast differentiation. When TNF was added to differentiated myotubes, there was no effect on muscle gene expression. In contrast, TNF-inducible mRNAs such as interferon beta-2 still responded, suggesting that the signal mediated by TNF binding to its receptor had no effect on muscle-specific genes after differentiation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3405207      PMCID: PMC363426          DOI: 10.1128/mcb.8.6.2295-2301.1988

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  36 in total

1.  Evolution of the human sarcomeric-actin genes: evidence for units of selection within the 3' untranslated regions of the mRNAs.

Authors:  P Gunning; T Mohun; S Y Ng; P Ponte; L Kedes
Journal:  J Mol Evol       Date:  1984       Impact factor: 2.395

2.  Cardiac actin is the major actin gene product in skeletal muscle cell differentiation in vitro.

Authors:  W Bains; P Ponte; H Blau; L Kedes
Journal:  Mol Cell Biol       Date:  1984-08       Impact factor: 4.272

3.  Reversibility of muscle differentiation in the absence of commitment: analysis of a myogenic cell line temperature-sensitive for commitment.

Authors:  H T Nguyen; R M Medford; B Nadal-Ginard
Journal:  Cell       Date:  1983-08       Impact factor: 41.582

4.  A macrophage factor inhibits adipocyte gene expression: an in vitro model of cachexia.

Authors:  F M Torti; B Dieckmann; B Beutler; A Cerami; G M Ringold
Journal:  Science       Date:  1985-08-30       Impact factor: 47.728

5.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.

Authors:  B Beutler; I W Milsark; A C Cerami
Journal:  Science       Date:  1985-08-30       Impact factor: 47.728

6.  Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor.

Authors:  J R Gamble; J M Harlan; S J Klebanoff; M A Vadas
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

7.  Isolation and characterization of full-length cDNA clones for human alpha-, beta-, and gamma-actin mRNAs: skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed.

Authors:  P Gunning; P Ponte; H Okayama; J Engel; H Blau; L Kedes
Journal:  Mol Cell Biol       Date:  1983-05       Impact factor: 4.272

8.  Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors.

Authors:  M R Shalaby; B B Aggarwal; E Rinderknecht; L P Svedersky; B S Finkle; M A Palladino
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

9.  Identity of tumour necrosis factor and the macrophage-secreted factor cachectin.

Authors:  B Beutler; D Greenwald; J D Hulmes; M Chang; Y C Pan; J Mathison; R Ulevitch; A Cerami
Journal:  Nature       Date:  1985 Aug 8-14       Impact factor: 49.962

10.  Induction of beta 2-interferon by tumor necrosis factor: a homeostatic mechanism in the control of cell proliferation.

Authors:  M Kohase; D Henriksen-DeStefano; L T May; J Vilcek; P B Sehgal
Journal:  Cell       Date:  1986-06-06       Impact factor: 41.582

View more
  40 in total

1.  Modeling the Effect of TNF-α upon Drug-Induced Toxicity in Human, Tissue-Engineered Myobundles.

Authors:  Brittany N J Davis; Jeffrey W Santoso; Michaela J Walker; Catherine E Oliver; Michael M Cunningham; Christian A Boehm; Danielle Dawes; Samantha L Lasater; Kim Huffman; William E Kraus; George A Truskey
Journal:  Ann Biomed Eng       Date:  2019-04-08       Impact factor: 3.934

2.  Serum creatinine level, a surrogate of muscle mass, predicts mortality in critically ill patients.

Authors:  Charat Thongprayoon; Wisit Cheungpasitporn; Kianoush Kashani
Journal:  J Thorac Dis       Date:  2016-05       Impact factor: 2.895

3.  TNFalpha inhibits skeletal myogenesis through a PW1-dependent pathway by recruitment of caspase pathways.

Authors:  Dario Coletti; Ellen Yang; Giovanna Marazzi; David Sassoon
Journal:  EMBO J       Date:  2002-02-15       Impact factor: 11.598

4.  Cytokine profiling in patients with VCP-associated disease.

Authors:  Eric Dec; Prachi Rana; Veeral Katheria; Rachel Dec; Manaswitha Khare; Angèle Nalbandian; Szu-Yun Leu; Shlomit Radom-Aizik; Katrina Llewellyn; Lbachir BenMohamed; Frank Zaldivar; Virginia Kimonis
Journal:  Clin Transl Sci       Date:  2013-10-03       Impact factor: 4.689

Review 5.  Shared signaling systems in myeloid cell-mediated muscle regeneration.

Authors:  James G Tidball; Kenneth Dorshkind; Michelle Wehling-Henricks
Journal:  Development       Date:  2014-03       Impact factor: 6.868

6.  Iron-independent induction of ferritin H chain by tumor necrosis factor.

Authors:  L L Miller; S C Miller; S V Torti; Y Tsuji; F M Torti
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

Review 7.  Impaired regeneration: A role for the muscle microenvironment in cancer cachexia.

Authors:  Erin E Talbert; Denis C Guttridge
Journal:  Semin Cell Dev Biol       Date:  2015-09-16       Impact factor: 7.727

8.  Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vivo and in vitro.

Authors:  H Ito; S C Miller; M E Billingham; H Akimoto; S V Torti; R Wade; R Gahlmann; G Lyons; L Kedes; F M Torti
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

9.  RIP2, a checkpoint in myogenic differentiation.

Authors:  Barbara Munz; Eberhard Hildt; Matthew L Springer; Helen M Blau
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

10.  Genomic profiling of messenger RNAs and microRNAs reveals potential mechanisms of TWEAK-induced skeletal muscle wasting in mice.

Authors:  Siva K Panguluri; Shephali Bhatnagar; Akhilesh Kumar; John J McCarthy; Apurva K Srivastava; Nigel G Cooper; Robert F Lundy; Ashok Kumar
Journal:  PLoS One       Date:  2010-01-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.